Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, EQUIFAX INC insiders sold a net $15.3M of stock across 270 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
94 earlier Form 4 trades (code P or S) here by this insider (94 sales), the last on Jul 24, 2026.
The trade is 11.6% of the 289,922 shares held after it.
No other insider sold within 30 days.
375 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO Begor Mark W sold about $6.1M of EFX under a 10b5-1 plan on Oct 23, 2026, the largest insider sale at the company since 2024; 375 funds added in the latest 13F quarter.
23 earlier Form 4 trades (code P or S) here by this insider (23 sales), the last on May 1, 2026.
The trade is 6.5% of the 69,055 shares held after it.
No other insider sold within 30 days.
375 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, CFO & COO GAMBLE JOHN W JR sold about $845.8K of EFX under a 10b5-1 plan on Sep 3, 2026; 375 funds added in the latest 13F quarter.
270 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
EFX planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Begor Mark W
Filed 2026-10-23
$6.9M
Mao Cecilia
Filed 2026-10-23
$1.5M
GAMBLE JOHN W JR
Filed 2026-09-03
$845.8K
Begor Mark W
Filed 2026-07-24
$6.5M
EFX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Vulcan Value Partners Fund
$10.1M position · as of 2026-07-31
4.4%
Invesco Bloomberg Financial Data Providers ETF
$1.8M position · as of 2026-05-31
3.6%
Fidelity Disruptive Finance ETF
$1.4M position · as of 2026-05-31
3.4%
Weitz Large Cap Equity Fund
$19.7M position · as of 2026-06-30
3.1%
Eaton Vance Atlanta Capital Focused Growth Fund
$14.4M position · as of 2026-06-30
3.1%
Lazard Equity Franchise Portfolio
$1.1M position · as of 2026-06-30
3.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mark W. Begor
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$23.4M
-$3.7M
$6.3M
+17%
+69%
2024
$14.8M
$13.1M
$6.6M
+36%
+50%
2023
$13.0M
$32.1M
$6.2M
+31%
+21%
2022
$37.2M
-$19.0M
$3.7M
+2%
+15%
2021
$16.1M
$84.9M
$4.0M
+53%
+34%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $15.3M sold by insiders over 180 days, 375 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $9.3M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$6.6B
four quarters, 2025-10-01 to 2026-09-30
Revenue, TTM EFX
FY Dec 2025
$6.1B
FY Dec 2024
$5.7B
FY Dec 2023
$5.3B
FY Dec 2022
$5.1B
FY Dec 2021
$4.9B
Sep 2026
$1.7B
Jun 2026
$1.7B
Mar 2026
$1.6B
Dec 2025
$1.6B
Sep 2025
$1.5B
Jun 2025
$1.5B
Mar 2025
$1.4B
Dec 2024
$1.4B
At each fiscal year end
Single quarter
Net margin, TTM
+11.3%
net income over revenue, 2025-10-01 to 2026-09-30
Net margin, TTM EFX
FY Dec 2025
+10.9%
FY Dec 2024
+10.6%
FY Dec 2023
+10.4%
FY Dec 2022
+13.6%
FY Dec 2021
+15.1%
Sep 2026
+12.5%
Jun 2026
+10.8%
Mar 2026
+10.4%
Dec 2025
+11.3%
Sep 2025
+10.4%
Jun 2025
+12.4%
Mar 2025
+9.2%
Dec 2024
+12.3%
At each fiscal year end
Single quarter
Free cash flow, TTM
$1.1B
operating cash flow minus capex, 2025-10-01 to 2026-09-30
Free cash flow, TTM EFX
FY Dec 2025
$1.1B
FY Dec 2024
$813.0M
FY Dec 2023
$515.5M
FY Dec 2022
$132.6M
FY Dec 2021
$865.8M
Sep 2026
$436.9M
Jun 2026
$204.8M
Mar 2026
$121.5M
Dec 2025
$340.8M
Sep 2025
$437.9M
Jun 2025
$238.9M
Mar 2025
$116.7M
Dec 2024
$205.9M
At each fiscal year end
Single quarter
Debt to equity
1.16x
long-term 2026-09-30 plus current 2026-09-30; equity 2026-09-30
Debt to equity EFX
FY Dec 2025
1.11x
FY Dec 2024
1.04x
FY Dec 2023
1.26x
FY Dec 2022
1.46x
FY Dec 2021
1.48x
Sep 2026
1.16x
Jun 2026
1.25x
Mar 2026
1.17x
Dec 2025
1.11x
Sep 2025
0.97x
Jun 2025
0.96x
Mar 2025
1.00x
Dec 2024
1.04x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.31x
TTM operating cash flow over long-term 2026-09-30 plus current 2026-09-30
Cash flow to debt EFX
FY Dec 2025
0.32x
FY Dec 2024
0.26x
FY Dec 2023
0.20x
FY Dec 2022
0.13x
FY Dec 2021
0.25x
Sep 2026
0.31x
Jun 2026
0.29x
Mar 2026
0.31x
Dec 2025
0.32x
Sep 2025
0.31x
Jun 2025
0.28x
Mar 2025
0.26x
Dec 2024
0.26x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+15.8%
TTM net income over average of 2025-09-30 and 2026-09-30
Return on equity EFX
FY Dec 2025
+14.0%
FY Dec 2024
+12.9%
FY Dec 2023
+12.8%
FY Dec 2022
+18.5%
FY Dec 2021
+22.0%
Sep 2026
+15.8%
Jun 2026
+14.6%
Mar 2026
+14.7%
Dec 2025
+14.0%
Sep 2025
+13.4%
Jun 2025
+13.1%
Mar 2025
+12.8%
Dec 2024
+12.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+6.3%
TTM net income over average of 2025-09-30 and 2026-09-30
Return on assets EFX
FY Dec 2025
+5.6%
FY Dec 2024
+5.0%
FY Dec 2023
+4.6%
FY Dec 2022
+6.2%
FY Dec 2021
+7.2%
Sep 2026
+6.3%
Jun 2026
+5.8%
Mar 2026
+5.9%
Dec 2025
+5.6%
Sep 2025
+5.4%
Jun 2025
+5.3%
Mar 2025
+5.1%
Dec 2024
+5.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+9.3%
operating income after a 26.8% effective tax rate, over long-term 2026-09-30 plus current 2026-09-30 plus average of 2025-09-30 and 2026-09-30 minus cash
Return on invested capital EFX
FY Dec 2025
+8.5%
FY Dec 2024
+8.2%
FY Dec 2023
+7.4%
FY Dec 2022
+8.5%
FY Dec 2021
+11.6%
Sep 2026
+9.3%
Jun 2026
+8.5%
Mar 2026
+8.6%
Dec 2025
+8.5%
Sep 2025
+8.7%
Jun 2025
+8.3%
Mar 2025
+8.2%
Dec 2024
+8.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+12.2%
operating income (EBIT proxy) over average of 2025-09-30 and 2026-09-30 minus current liabilities
Return on capital employed EFX
FY Dec 2025
+11.2%
FY Dec 2024
+10.3%
FY Dec 2023
+9.4%
FY Dec 2022
+11.6%
FY Dec 2021
+14.3%
Sep 2026
+12.2%
Jun 2026
+11.9%
Mar 2026
+11.7%
Dec 2025
+11.2%
Sep 2025
+10.8%
Jun 2025
+10.6%
Mar 2025
+10.3%
Dec 2024
+10.3%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
28.89x
close 2026-10-26 over four quarters of diluted EPS, 2025-10-01 to 2026-09-30
P/E, trailing EFX
FY Dec 2025
40.86x
FY Dec 2024
52.65x
FY Dec 2023
56.20x
FY Dec 2022
34.40x
FY Dec 2021
48.64x
Sep 2026
22.21x
Jun 2026
27.94x
Mar 2026
31.76x
Dec 2025
40.86x
Sep 2025
48.59x
Jun 2025
50.66x
Mar 2025
49.71x
Dec 2024
52.65x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$25.9B
market value at close 2026-10-26 on 2026-10-09 shares, plus long-term 2026-09-30 plus current 2026-09-30, minus cash 2026-09-30
Enterprise value EFX
FY Dec 2025
$31.5B
FY Dec 2024
$36.4B
FY Dec 2023
$36.0B
FY Dec 2022
$29.3B
FY Dec 2021
$40.8B
Sep 2026
$21.1B
Jun 2026
$24.2B
Mar 2026
$26.8B
Dec 2025
$31.5B
Sep 2025
$36.4B
Jun 2025
$36.9B
Mar 2025
$35.0B
Dec 2024
$36.4B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.3%
TTM free cash flow over market value at close 2026-10-26
FCF yield EFX
FY Dec 2025
+4.3%
FY Dec 2024
+2.6%
FY Dec 2023
+1.7%
FY Dec 2022
+0.6%
FY Dec 2021
+2.4%
Sep 2026
+6.8%
Jun 2026
+5.8%
Mar 2026
+5.3%
Dec 2025
+4.3%
Sep 2025
+3.1%
Jun 2025
+2.8%
Mar 2025
+2.7%
Dec 2024
+2.6%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.70x
P/E over trailing EPS growth of 17%: four quarters to 2026-09-30 against the four to 2025-09-30
PEG, trailing EFX
FY Dec 2025
4.21x
FY Dec 2024
5.27x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
1.16x
Sep 2026
1.30x
Jun 2026
2.55x
Mar 2026
2.02x
Dec 2025
4.21x
Sep 2025
2.80x
Jun 2025
5.39x
Mar 2025
5.44x
Dec 2024
5.27x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
EFX ranks highest on institutional and government (77th percentile) and growth (75th), and lowest on insider conviction (9th), among Services peers.
Profitability
60
Inputs
Return on equity+15.8% · 69 pct, sector of 207
Return on assets+6.3% · 74 pct, sector of 269
Return on invested capital+9.3% · 30 pct, sector of 81
Return on capital employed+12.2% · 68 pct, sector of 203
Financial health
40
Inputs
Debt to equity1.16x · 23 pct, sector of 228
Cash flow to debt0.31x · 57 pct, sector of 199
Growth
75
Inputs
Revenue growth, YoY+6.9% · 56 pct, sector of 341
Backlog growth, YoY+62.1% · 93 pct, sector of 77
Insider conviction
9
Inputs
Net Form 4 buying (codes P and S), 180d-$7.6M · 19 pct, sector of 175
Insider buyers, 180d0 · 0 pct, sector of 180
Institutional and government
77
Inputs
Funds adding, latest quarter375 · 90 pct, sector of 243
Congress net buyers, 365d0 · 56 pct, sector of 37
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$3.6M · 87 pct, sector of 61
Risk and compliance
42
Inputs
Short interest, % of float+4.8% · 37 pct, sector of 384
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+13.0% · 46 pct, sector of 227
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
EFX filings, in plain words
Are Equifax insiders buying or selling EFX?
In the 180 days to 2026-10-28, Equifax insiders were net sellers, a net $15.3M across purchases and sales reported on Form 4, by 3 sellers.
Have members of Congress traded EFX?
Yes. In the year to 2026-10-28, 1 House member disclosed buying EFX and 1 House member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-04-14.
Are there planned insider sales of EFX?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $9.3M of stock; the latest, by Begor Mark W, was filed 2026-10-23.
Read the full summary
In the 180 days to 2026-10-28, Equifax insiders were net sellers of EFX, a net $15.3M across purchases and sales reported on Form 4 by 3 sellers. 33% of the 15 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-28, 1 member of Congress disclosed buying EFX and 1 member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-04-14. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $9.3M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.